NRX Historical Income Statement
| NRXP Stock | USD 1.31 0.02 1.55% |
Historical analysis of NRX Pharmaceuticals income statement accounts such as Tax Provision of 0.0 can show how well NRX Pharmaceuticals performed in making a profits. Evaluating NRX Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of NRX Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining NRX Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether NRX Pharmaceuticals is a good buy for the upcoming year.
NRX |
About NRX Income Statement Analysis
NRX Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to NRX Pharmaceuticals shareholders. The income statement also shows NRX investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
NRX Pharmaceuticals Income Statement Chart
Add Fundamental
Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Operating Income
Operating Income is the amount of profit realized from NRX Pharmaceuticals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of NRX Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on NRX Pharmaceuticals income statement and is an important metric when analyzing NRX Pharmaceuticals profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of NRX Pharmaceuticals. It is also known as NRX Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from NRX Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into NRX Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRX Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.At this time, NRX Pharmaceuticals' Selling General Administrative is relatively stable compared to the past year. As of 11/29/2024, Other Operating Expenses is likely to grow to about 32.9 M, while Operating Income is likely to drop (29 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 94.4M | 44.4M | 27.6M | 32.9M | Cost Of Revenue | 2K | 4K | 5K | 4.8K |
NRX Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
NRX Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
NRX Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Income | 1.2M | 138.8K | 0.0 | 249K | 550K | 372.8K | |
| Selling General Administrative | 2.8K | 11.4M | 74.9M | 27.4M | 14.2M | 20.3M | |
| Operating Income | (6.3K) | (51.4M) | (115.8M) | (44.4M) | (27.6M) | (29.0M) | |
| Income Before Tax | 492.6K | (51.8M) | (93.1M) | (39.8M) | (30.2M) | (31.7M) | |
| Net Income Applicable To Common Shares | (6.7M) | (51.8M) | (348.9M) | (39.8M) | (35.8M) | (37.6M) | |
| Net Income | 408.4K | (12.3M) | (71.7M) | (35.2M) | (30.2M) | (31.7M) | |
| Other Operating Expenses | 6.4K | 11.9M | 94.4M | 44.4M | 27.6M | 32.9M | |
| Ebit | (6.3K) | (51.7M) | (93.0M) | (39.8M) | (30.0M) | (31.5M) | |
| Ebitda | (6.3K) | (51.7M) | (93.0M) | (39.8M) | (30.0M) | (31.5M) | |
| Total Operating Expenses | 6.4K | 11.9M | 94.4M | 44.4M | 27.6M | 32.9M | |
| Total Other Income Expense Net | 492.6K | (39.9M) | 22.7M | 4.6M | (2.6M) | (2.7M) | |
| Income Tax Expense | 84.2K | (39.4M) | (21.3M) | (4.6M) | (9K) | (9.5K) |
Pair Trading with NRX Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NRX Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRX Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with NRX Stock
Moving against NRX Stock
| 0.88 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.81 | GILD | Gilead Sciences | PairCorr |
| 0.8 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.8 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.73 | GANX | Gain Therapeutics | PairCorr |
The ability to find closely correlated positions to NRX Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NRX Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NRX Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NRX Pharmaceuticals to buy it.
The correlation of NRX Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NRX Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NRX Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NRX Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for NRX Stock Analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.